Table 2.
Asthma, rhinoconjunctivitis, and eczema among the children who participated in the six-year follow-up survey.
| Variable | Number | Prevalence (%) |
|---|---|---|
| Wheeze ever | 136 | 11.3 |
| Wheeze in the past 12 months | 61 | 5.1 |
| 4 or more attacks of wheeze in the past 12 months | 12 | 1.0 |
| Sleep disturbance from wheeze, 1 or more nights a week in the past 12 months | 4 | 0.3 |
| Speech limited by wheeze in the past 12 months | 4 | 0.3 |
| Asthma ever | 38 | 3.2 |
| Wheeze during or after exercise in the past 12 months | 18 | 1.5 |
| Night cough in the past 12 months | 156 | 13.0 |
| Asthma | 61 | 5.1 |
| Nose symptoms ever | 573 | 47.7 |
| Nose symptoms in the past 12 months | 409 | 34.0 |
| Nose and eye symptoms in the past 12 months | 138 | 11.5 |
| Nose symptoms affecting activities a lot in the past 12 months | 10 | 0.8 |
| Hay fever ever | ― | ― |
| Rhinoconjunctivitis | 138 | 11.5 |
| Rash ever | 126 | 10.5 |
| Rash in the past 12 months | 94 | 7.8 |
| Flexural rash | 80 | 6.7 |
| Complete clearance of rash in the past 12 months | 68 | 5.7 |
| Sleep disturbance from rash, 1 or more nights a week in the past 12 months | 4 | 0.3 |
| Eczema ever | 19 | 1.6 |
| Eczema | 80 | 6.7 |
| Number of participants | 1202 |